ANGO
AngioDynamics Inc
15.50$
+1.4%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 49.1% | 49.1% | 52.3% | 45.7% | 45.6% | 45.2% | 46.0% | 47.3% | 44.7% | 46.9% | 47.1% | 42.9% | 45.4% | |
| 50.9% | 50.9% | 47.7% | 54.3% | 54.4% | 54.8% | 54.0% | 52.7% | 55.3% | 53.1% | 52.9% | 57.1% | 54.6% | |
| 10.1% | 10.9% | 10.9% | 9.5% | 9.3% | 8.8% | 9.6% | 8.2% | 8.5% | 9.8% | 9.0% | 9.4% | 9.2% | |
| 13.8% | 11.7% | 14.1% | 14.7% | 16.3% | 14.3% | 14.6% | 12.8% | 16.6% | 12.8% | 13.7% | 11.9% | 13.6% | |
| 6.4% | 67.5% | 313.6% | 74.6% | 73.8% | 70.0% | 67.8% | 59.9% | 69.4% | 56.2% | 61.1% | 80.6% | 67.1% | |
| 44.5% | -16.6% | -265.9% | -20.4% | -19.4% | -15.2% | -13.9% | -7.2% | -14.1% | -3.1% | -8.2% | -23.5% | -12.5% | |
| 0.2% | 0.7% | 0.5% | 0.8% | – | – | – | – | 0.0% | 0.1% | 0.1% | 0.1% | 0.1% | |
| 44.3% | -16.0% | -265.7% | -19.9% | -18.8% | -14.9% | -6.1% | -7.6% | -14.3% | -8.0% | -10.3% | -12.7% | -11.3% | |
| -14.0% | 20.8% | -16.0% | -1.0% | 0.2% | -0.2% | 0.0% | -0.1% | 0.1% | 0.0% | 0.0% | 0.4% | 0.1% | |
| 58.3% | -36.7% | -249.7% | -18.9% | -19.0% | -14.7% | -6.1% | -7.5% | -14.4% | -8.0% | -10.3% | -13.2% | -11.5% | |
| -3.9% | 0.0% | -5.4% | 1.4% | -2.9% | 2.5% | -0.5% | 2.7% | -6.4% | -0.5% | -3.1% | -32.7% | -11.2% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.